tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Arcturus Therapeutics Holdings Inc

ARCT
Add to Watchlist
7.410USD
+1.330+21.88%
Close 08-07 16:00（ET）Quotes delayed by 15 min
210.61MMarket Cap
LossP/E TTM

Arcturus Therapeutics Holdings Inc

7.410
+1.330+21.88%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

ARCT Financials

See Arcturus Therapeutics Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Arcturus Therapeutics Holdings Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-0.84/-1.00
Revenue / Forecast
880.00K/3.20M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
82.03M
-46.14%
EPS(YoY)
-2.40
19.87%
Analyst Rating
BUY
2026/08/09
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-147.30%-0.84
-82.70%-0.95
6.63%-1.03
-93.91%-0.49
47.00%-0.34
47.95%-0.52
-153.89%-1.11
58.21%-0.26
67.73%-0.64
-152.20%-1.00
-109.86%-0.44
---0.61
---1.98
--1.91
--4.43
---4.09
----
----
----
----
Revenue
-89.54%2.96M
-92.99%2.06M
-68.39%7.20M
-58.84%17.15M
-43.24%28.30M
-22.70%29.38M
-26.22%22.77M
-7.68%41.67M
373.99%49.86M
-52.65%38.01M
-80.75%30.86M
237.65%45.14M
-61.17%10.52M
1430.99%80.28M
2666.53%160.29M
448.58%13.37M
1253.97%27.09M
146.54%5.24M
158.89%5.79M
4.46%2.44M
Net Profit
-159.10%-23.79M
-91.56%-26.96M
3.09%-29.08M
-94.81%-13.45M
46.68%-9.18M
47.51%-14.08M
-156.30%-30.00M
57.45%-6.90M
67.24%-17.22M
-152.84%-26.82M
-109.98%-11.71M
54.00%-16.22M
-143.70%-52.55M
199.19%50.75M
403.51%117.35M
34.79%-35.27M
60.49%-21.56M
9.19%-51.17M
-24.30%-38.66M
-157.49%-54.08M
Net Margin
-2378.09%-803.82%
-2630.92%-1308.30%
-206.61%-404.10%
-373.35%-78.41%
6.06%-32.44%
32.09%-47.91%
-247.37%-131.80%
53.91%-16.56%
93.09%-34.53%
-211.60%-70.55%
-151.83%-37.94%
---35.94%
---499.57%
--63.22%
--73.21%
---236.29%
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
Debt to assets ratio
----
----
----
----
----
--4.52%
----
----
----
----
-100.00%0.00%
--4.37%
--0.00%
--0.00%
--13.47%
--20.35%
----
----
----
----
Income Statement
Revenue
-89.54%2.96M
-92.99%2.06M
-68.39%7.20M
-58.84%17.15M
-43.24%28.30M
-22.70%29.38M
-26.22%22.77M
-7.68%41.67M
373.99%49.86M
-52.65%38.01M
-80.75%30.86M
237.65%45.14M
-61.17%10.52M
1430.99%80.28M
2666.53%160.29M
448.58%13.37M
1253.97%27.09M
146.54%5.24M
158.89%5.79M
4.46%2.44M
Operating profit
-119.91%-25.55M
-71.94%-28.93M
6.25%-31.31M
-53.79%-16.51M
45.02%-11.62M
44.67%-16.83M
-82.76%-33.39M
44.41%-10.74M
61.85%-21.13M
-306.11%-30.41M
-115.04%-18.27M
47.53%-19.31M
-150.69%-55.37M
129.29%14.76M
422.62%121.45M
31.61%-36.81M
58.88%-22.09M
12.64%-50.38M
-21.12%-37.65M
-157.05%-53.82M
Net Profit
-159.10%-23.79M
-91.56%-26.96M
3.09%-29.08M
-94.81%-13.45M
46.68%-9.18M
47.51%-14.08M
-156.30%-30.00M
57.45%-6.90M
67.24%-17.22M
-152.84%-26.82M
-109.98%-11.71M
54.00%-16.22M
-143.70%-52.55M
199.19%50.75M
403.51%117.35M
34.79%-35.27M
60.49%-21.56M
9.19%-51.17M
-24.30%-38.66M
-157.49%-54.08M
Balance Sheet
Current assets
-28.18%197.16M
-22.21%216.88M
-21.09%241.45M
-24.67%249.20M
-20.89%274.50M
-25.81%278.79M
-20.85%305.98M
-15.88%330.82M
-9.93%347.01M
-11.49%375.79M
-4.15%386.59M
59.42%393.27M
32.16%385.24M
29.83%424.56M
6.43%403.33M
-41.40%246.68M
-33.45%291.50M
-30.42%327.00M
-18.99%378.96M
34.02%420.97M
Total current liabilities
-27.90%33.54M
-30.44%34.37M
-44.45%36.38M
-54.37%31.70M
-49.28%46.52M
-57.20%49.41M
-20.12%65.49M
-20.78%69.46M
1.52%91.72M
28.07%115.43M
-35.43%81.99M
15.60%87.68M
-2.59%90.34M
-16.01%90.13M
27.57%126.98M
-35.85%75.85M
31.05%92.74M
101.20%107.31M
101.00%99.54M
322.07%118.24M
Total assets
-27.47%224.31M
-26.03%245.41M
-21.19%271.15M
-23.83%282.34M
-20.42%309.27M
-20.79%331.79M
-19.87%344.07M
-19.01%370.65M
-9.76%388.61M
-11.05%418.85M
-4.66%429.40M
55.86%457.65M
27.78%430.65M
37.68%470.86M
14.66%450.39M
-32.43%293.63M
-24.91%337.01M
-28.97%341.99M
-17.56%392.81M
34.73%434.54M
Total liabilities
-32.88%52.50M
-44.86%54.05M
-44.55%57.16M
-46.88%57.78M
-39.84%78.22M
-36.71%98.03M
-31.68%103.09M
-38.74%108.79M
-10.62%130.03M
9.36%154.88M
-16.21%150.89M
20.02%177.59M
-12.52%145.47M
-9.94%141.62M
9.40%180.07M
-15.65%147.96M
16.16%166.30M
22.02%157.24M
106.00%164.60M
188.08%175.41M
Total equity
-25.64%171.81M
-18.14%191.36M
-11.20%213.99M
-14.25%224.56M
-10.65%231.05M
-11.45%233.76M
-13.48%240.98M
-6.50%261.87M
-9.32%258.58M
-19.83%263.97M
3.03%278.51M
92.26%280.06M
67.05%285.18M
78.21%329.25M
18.45%270.31M
-43.79%145.67M
-44.15%170.72M
-47.60%184.75M
-42.45%228.21M
-0.96%259.13M
Cash Flow Statement
Net operating income
-245.96%-19.91M
44.67%-19.44M
-5613.73%-16.23M
27.83%-17.15M
80.91%-5.75M
-532.32%-35.14M
54.85%-284.00K
26.67%-23.76M
-159.33%-30.14M
84.51%-5.56M
-100.39%-629.00K
23.58%-32.41M
237.98%50.81M
26.85%-35.87M
477.11%160.26M
-154.64%-42.41M
-11.77%-36.82M
-14.18%-49.04M
-540.79%-42.50M
-4.89%-16.65M
Net investment
--18.00K
124.82%34.00K
--88.00K
-126.25%-181.00K
100.00%0.00
42.92%-137.00K
100.00%0.00
91.85%-80.00K
7.34%-328.00K
65.27%-240.00K
77.02%-875.00K
55.12%-981.00K
-193.65%-354.00K
67.27%-691.00K
-240.52%-3.81M
-23.78%-2.19M
193.56%378.00K
-1688.98%-2.11M
-60.40%-1.12M
-306.91%-1.77M
Net financing
100.00%0.00
-99.89%16.00K
8622.39%11.69M
76.77%1.23M
-712.82%-14.73M
594.47%15.20M
100.72%134.00K
-96.83%693.00K
2456.38%2.40M
108.00%2.19M
-735.89%-18.66M
1890.16%21.84M
-63.42%94.00K
-8244.05%-27.36M
-1070.43%-2.23M
-276.30%-1.22M
213.41%257.00K
-99.29%336.00K
-99.86%230.00K
-99.63%692.00K

FAQs

What is the total revenue of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its total revenue reached 82.03M, with a year-on-year change of 152.31M.

What are the current assets of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its current assets were 241.45M, with a year-on-year change of -21.09.

What are the total assets of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its total assets of Arcturus Therapeutics Holdings Inc were 271.15M, with a year-on-year change of -21.19.

What are the total liabilities of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its total liabilities of Arcturus Therapeutics Holdings Inc were 57.16M, with a year-on-year change of -44.55.

What is the total equity of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its total equity of Arcturus Therapeutics Holdings Inc was 213.99M, with a year-on-year change of -11.20.

What is the net operating income of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its net operating income of Arcturus Therapeutics Holdings Inc was -76.26M, with a year-on-year change of 20.29.

What is the net investment of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its net investment of Arcturus Therapeutics Holdings Inc was -230.00K, with a year-on-year change of 64.51.

What is the net financing of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its net financing of Arcturus Therapeutics Holdings Inc was 13.38M, with a year-on-year change of 146.99.

What is the Earnings Per Share (EPS) of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.40, with a year-on-year change of 19.87.

What is the net income of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its net income was -65.78M, with a year-on-year change of 18.73.

What is the net margin of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its net profit margin was -80.19, with a year-on-year change of -50.90.

What is the Return on Equity (ROE) of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was -28.92, with a year-on-year change of 7.20.

What is the Return on Assets (ROA) of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -21.39, with a year-on-year change of -2.18.

What is the operating profit of Arcturus Therapeutics Holdings Inc?

According to Arcturus Therapeutics Holdings Inc's FY2025 earnings report, its operating profit was -76.26M, with a year-on-year change of 20.29.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy